Atorvastatin Calcium
NDC 70882-102
Product Information
Atorvastatin Calcium is a ANDA-approved product labeled by Cambridge Therapeutics Technologies, Llc. Atorvastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. It is supplied as a yellow product. This product entry covers the primary NDC 70882-102 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
9 MM
HLA;10
HLA;20
Code Structure Chart
Product Details
What is NDC 70882-102?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ATORVASTATIN CALCIUM (UNII: 48A5M73Z4Q)
- ATORVASTATIN (UNII: A0JWA85V8F) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
- GLYCERIN (UNII: PDC6A3C0OX)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- STARCH, CORN (UNII: O8232NY3SJ)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)
- TALC (UNII: 7SEV7J4R1U)
- TROMETHAMINE (UNII: 023C2WHX2V)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 617310 - atorvastatin calcium 20 MG Oral Tablet
- RxCUI: 617310 - atorvastatin 20 MG Oral Tablet
- RxCUI: 617310 - atorvastatin (as atorvastatin calcium) 20 MG Oral Tablet
- RxCUI: 617312 - atorvastatin calcium 10 MG Oral Tablet
- RxCUI: 617312 - atorvastatin 10 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.